Four task forces travelled to New York City, three are deploying to New Jersey, and one is headed to Connecticut, said Army Secretary Ryan D. McCarthy. McCarthy discussed the task forces and other measures the Army is taking to combat the COVID-19 pandemic during a media roundtable Friday at the Pentagon.
Urban Augmentation Medical Task Force 338-1 Mobilizes
Army scientists at the U.S. Army Medical Research and Development Command at Fort Detrick, Maryland, have been working with researchers from across the globe on COVID-19 vaccines. McCarthy said six possible vaccines have shown the most promise; four are being tested on animals, and two on human subjects. Additionally, two soldiers diagnosed with coronavirus were given an antiviral drug used to treat the Ebola virus, and they successfully recovered, McCarthy said.
”They’re up and walking around,” McCarthy said. ”Obviously, that’s not that substantial of a sample size, but it shows that it can work.”
McCarthy, who met with USAMRDC Commander Brig. Gen. Michael Talley, said the research staff has been working relentlessly to find a viable vaccine.
Army Maj. Gen. Michael O’Guinn, deputy chief of the Army Reserve, serves lunch to soldiers of Task Force 338-1 on April 7, 2020, at the John E. Smathers Reserve Center, Fort Meade, MD. TF 338-1 is an Urban Augmentation Medical Task Force mobilizing to New York to combat the COVID-19 pandemic. (Photo by Army Spc. William Roulett)
”If you look across all our lines of operation, our labs are working 24 hours a day in the pursuit of vaccine,” McCarthy said.
To build the Urban Augmentation Medical Task Forces, the Army called up medical professionals from Army Reserve units across the country. The Reserve volunteers were vetted to ensure they were not already engaged in the battle against coronavirus in their own communities, said Army Chief of Staff Gen. James C. McConville.
”We did not want to take medical personnel out of civilian communities where they were actually fighting the virus,” he said.
Each task force consists of 85 people, and each has the capability of providing the same service as a 250-bed hospital, McConville said.
”We went ahead, and we knew that there was going to be a lot of demand for medical professionals,” McConville said. ”…We put together these 15 Urban Augmentation Medical Task Forces, and they are motivated and ready to go.”
The task forces deployed to Joint Base McGuire-Dix-Lakehurst, New Jersey, before moving on to the hospitals where they will augment staff. Some of the units will support patients receiving treatment at the Javits Convention Center in New York City. Others will augment community hospitals.
Each task force has 14 physicians – including an infectious disease specialist and four respiratory specialists. In addition, each has 16 medics, 13 nurses, five physician assistants, two dentists, four pharmacists, two clinical psychologists, a psychiatrist, two occupational therapy specialists, four dieticians and 18 other supporting staff.
The task forces are designed to perform low-acuity care, officials said, but they can also test for COVID-19.
The remaining seven task forces are on standby and can be ready to travel within 24 hours once a location is identified by Army North and the Federal Emergency Management Agency, McConville said.
Spc. Montana Naccarato of Mount Gretna, P.A., assigned to the New York Army National Guard’s 69th Infantry Regiment, checks a motorist’s identification at a drive-thru COVID-19 sampling site outside the Aqueduct Racetrack in Queens, N.Y., April 6, 2020. New York National Guard members are supporting the multi-agency response to COVID-19. (U.S. Air National Guard photo by Senior Airman Sean Madden)
About 25,000 National Guard troops have deployed across the United States and its territories in support of the COVID-19 response. Guardsmen have built mobile COVID-19 test sites to relieve some of the burden of screening emergency room patients for coronavirus at treatment facilities in Miami and Chicago, McCarthy said. He added that the test sites will be able to process thousands of screenings at a faster rate.
”What it does if you go from the screening to the recovery point and the healthcare continuum, it helps create an arm’s reach in the screening … instead of overrunning an emergency room with hundreds of people, which then presents the challenge for health care professionals to not getting sick,” McCarthy said. ”So by going to the (mobile test site), you can have many of these people get diagnosed, they get prescriptions, and they go home as opposed to overwhelming emergency rooms.”
McCarthy said he plans to visit both test sites next week.